Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma

This publication has 33 references indexed in Scilit:

• Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group
  Journal of Clinical Oncology, 2009
• Treatment of advanced hepatocellular carcinoma with long-acting octreotide: A phase III multicentre, randomised, double blind placebo-controlled study
  European Journal Of Cancer, 2009
• Survival End Point Reporting in Randomized Cancer Clinical Trials: A Review of Major Journals
  Journal of Clinical Oncology, 2008
• Sorafenib in Advanced Hepatocellular Carcinoma
  New England Journal of Medicine, 2008
• Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402)
  European Journal Of Cancer, 2008
• Standardizing Patient-Reported Outcomes Assessment in Cancer Clinical Trials: A Patient-Reported Outcomes Measurement Information System Initiative
  Journal of Clinical Oncology, 2007
• Symptom Improvement in Lung Cancer Patients Treated With Erlotinib: Quality of Life Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21
  Journal of Clinical Oncology, 2006
• Critical review of the international assessments of health-related quality of life
  Quality of Life Research, 1993
• Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnoses
  Quality of Life Research, 1993
• The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
  JNCI Journal of the National Cancer Institute, 1993